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Abstract
Background: An increased risk for glomerulonephritis and a higher prevalence of antibodies to Borrelia (B.)
burgdorferi sensu lato have been reported in Bernese mountain dogs (BMDs). The aim of the study was to
determine the prevalence of laboratory abnormalities suggestive of kidney disease in clinically healthy BMDs
compared to a control population and to investigate if there is a correlation with the occurrence of antibodies to B.
burgdorferi sensu lato, Ehrlichia canis, and Anaplasma (A.) spp. and with the occurrence of Dirofilaria (D.) immitis
antigen.
A total of 197 BMDs and 57 control dogs were included in the study. Laboratory evidence of kidney disease was
defined as renal azotemia and/or proteinuria with a urine protein creatinine ration of more than 0.5 in an inactive
urine sediment. A SNAP®4Dx® ELISA (IDEXX, Laboratories, Inc., Westbrook, ME, USA) was used to detect antibodies
to B. burgdorferi sensu lato, E. canis and Anaplasma spp. and antigen of D. immitis.
Results: Laboratory evidence of kidney disease was significantly more common in BMDs than in control dogs
(17.8% versus 1.8%) (p = 0.005). The proportion of BMDs with anti-B. burgdorferi sensu latu antibodies and anti-A.
phagocytophilum antibodies was significantly higher in BMDs (p < 0.001). However, an association between these
findings could not be identified.
Conclusion: BMDs are more often affected by kidney disease and have a higher prevalence of antibodies to
bacterial pathogens transmitted by Ixodes ticks than control dogs. However, a causal relationship between these
two variables could not be established due to a lack of association between these two findings.
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Background
Chronic kidney disease is a common cause of morbidity
and mortality in dogs [1]. Some studies showed that
renal disease is one of the most frequent causes of death
in Bernese mountain dogs and among the diseases asso-
ciated with the shortest median survival time in this
breed [2, 3]. In previous studies, glomerular diseases
have been shown to occur more often in Bernese
mountain dogs (BMDs) than in other breeds [4–8]. An
increased incidence of glomerulonephritis in BMDs was
first described in 1991 in a doctoral thesis at the Univer-
sity of Zurich [9]. In this five-year retrospective study
and a following twenty-four months prospective study
[9], frequency, etiology, and laboratory parameters of
kidney diseases in BMDs were investigated. The histo-
logical changes in the kidneys in dogs presented a com-
plex picture of glomerular changes including
membranous, mesangioproliferative, membranoprolifera-
tive, and chronic-sclerosing types. A genetic cause could
neither be supported nor refuted through a pedigree
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analysis [9]. Subsequent studies described a BMD typical
membranoproliferative glomerulonephritis (MPGN) co-
morbid with interstitial nephritis [7, 8]. Based on pedi-
gree analysis, there was a high probability that the
susceptibility for MPGN in BMDs has a hereditary cause
[7]. Furthermore, the same study demonstrated the pres-
ence of IgG immunofluorescence assay (IFA) antibodies
to Borrelia (B.) burgdorferi sensu lato in all investigated
BMDs. However, immunohistochemical examination for
that organism in sections of the myocardium and kidney
was negative in all dogs. Therefore, this study and other
subsequent studies could not prove a causal relationship
between the presence of antibodies to B. burgdorferi
sensu lato and glomerular disease [7–13].
Several studies revealed a significantly higher preva-
lence of antibodies to B. burgdorferi sensu lato and to
Anaplasma (A.) phagocytophilum in BMDs than in con-
trol dogs indicating a higher infection prevalence [14,
15]. Chronic persistent infections, such as with B. burg-
dorferi sensu lato, Ehrlichia spp., and Anaplasma spp. as
well as Dirofilaria spp. are potential causes of glomerular
disease [16]. Despite the fact that an association of Bor-
relia spp. infection and the presence of kidney disease
has not convincingly been proven in dogs, in the United
States some authors describe a disease entity in Labrador
and Golden Retrievers as “Lyme nephritis” and it was
speculated whether this disease would be similar to what
is seen in BMD in Europe [17, 18].
So far, there are no large studies investigating the
prevalence of laboratory abnormalities suggestive for
kidney disease in BMDs in comparison to an age- and
weight-matched control group. It is also not clear if the
higher prevalence of Anaplasma spp. antibodies is asso-
ciated with a higher prevalence of laboratory abnormal-
ities indicating the presence of kidney disease.
The aim of the study was to determine the prevalence
of laboratory abnormalities suggestive of kidney diseases
in clinically healthy BMDs compared to a control popu-
lation. Furthermore, it was investigated whether there is
an association between serum biochemical and urinalysis
results suggestive of kidney disease and the presence of
antibodies to B. burgdorferi sensu lato, Ehrlichia canis,




The body weight ranged from 25 to 68 kg (median: 39.6
kg) in BMDs and from 30 to 67 kg in control dogs (me-
dian: 39.0 kg) (p = 0.437). The proportion of BMDs and
control dogs that lived in an urban area was similar
(29.9% versus 29.8%; p = 0.986). There were no signifi-
cant differences between BMDs and control dogs with
regard to the number of walks per week in a forest or
grassland (p = 0.660), tick exposure (p = 0.728), or rou-
tine tick prevention (p = 0.241). Likewise, other
questionnaire-related information did not differ signifi-
cantly between BMDs and control dogs (Table 1).
Laboratory findings
Haematocrit and the concentration of total protein did
not differ significantly between BMDs and control dogs.
However, BMDs had significantly higher albumin, cre-
atinine, urea and phosphorus concentrations than the
control dogs (Table 2). Results of urinalysis are illus-
trated in Table 3. There were no differences in the re-
sults of urine dipstick, urine sediment and urine specific
gravity (USG) between groups. Eight BMDs and one
control dog were excluded from the determination of
urine protein creatinine ratio (UPC) because micro-
scopic examination of urine sediment showed signs of
inflammation. The UPC of BMDs was significantly
higher than that of control dogs (p < 0.001). Proteinuria
with a UPC ≥ 0.5 (range 0.57–6.39, median 1.1) was seen
in 27/189 (14.3%) BMDs and 1/56 (1.8%) control dogs
(UPC 0.78) (p = 0.008). Ten of the proteinuric BMDs
had a UPC ≥ 2.
Renal azotemia (creatinine > 125 μmol/l and USG <
1.030) was diagnosed in 35/197 (17.8%) BMDs.
Twenty-seven of 197 (13.7%) BMDs had renal azotemia
and were also proteinuric (UPC > 0.5). In ten of these
BMDs, the UPC was ≥2.0 (5.1%). Among the control
dogs, 1/57 (1.6%) had renal azotemia. This dogs was pro-
teinuric as well. The proportion of dogs with evidence of
kidney disease was significantly higher in BMDs than in
control dogs (p = 0.005). Laboratory evidence of kidney
disease was significantly more common in male (77.1%;
27/35) than in female BMDs (22.9%; 8/35) (p < 0.005).
BMDs with evidence of kidney disease (mean 5.2 years
+/− 2.46) were significantly older than BMDs without
evidence of kidney disease (mean 3.7 years +/− 2.65)
(p = 0.002).
Prevalence of antibodies to B. burgdorferi sensu lato,
Ehrlichia canis, and Anaplasma spp. and of Dirofilaria
immitis antigen
Antibodies to B. burgdorferi sensu lato attributable to in-
fection were detected in 44.6% of BMDs (88/197) and in
21.1% of control dogs (12/57) (p = 0.001), and 46.2% of
BMDs (91/197) and 19.3% of control dogs (11/57) had
anti-Anaplasma spp. antibodies (p < 0.001). There was a
significant difference in the prevalence of anti-B. burg-
dorferi sensu latu antibodies (p = 0.001) (OR 3.03) and
anti- Anaplasma spp. antibodies (p < 0.001) (OR 3.59)
between BMDs and control dogs. There was no signifi-
cant association between the sex of BMDs and and the
presence of antibodies against B. burgdorferi sensu latu
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(p = 0.181), Anaplasma spp. (p = 0.371), or the presence
of both pathogens (p = 0.594).
Antibodies to B. burgdorferi sensu latu were present in
54.3% of BMDs (19/35) with evidence of kidney disease
and in 42.6% of BMDs (69/162) without evidence of kid-
ney disease (p = 0.209). Antibodies to Anaplasma spp.
were detected in 34.3% of BMDs (12/35) with evidence
of kidney disease and 48.8% of BMDs (79/162) without
evidence of kidney disease (p = 0.120). Antibodies to
both pathogens, B. burgdorferi sensu latu and Ana-
plasma spp. were detected in 22.3% (44/197) of BMDs
compared to 1.8% (1/57) of the control dogs (p < 0.001)
with no significant difference between BMDs with and
without evidence of kidney disease (11.4% (4/35) vs.
24.1% (40/162); p = 0.088). Regarding proteinuria alone,
there was no association between the presence of pro-
teinuria and the presence of antibodies against these
pathogens, neither the group of BMDs (p = 0,118) nor
in the control group (p = 0.404).
Of all dogs included in the study, only one BMD (1/
267) was positive for D. immitis antigen. This dog hat
renal azotemia (creatinine 167 μmol/ l, USG 1.015) and
was proteinuric with a UPC of 2.79. No dog in the study
had antibodies to Ehrlichia canis (Table 4).
Discussion
In the present study, 17.8% of the BMDs had laboratory
evidence of kidney disease compared to 1.6% of the
Table 1 Signalment and history of all dogs included in the study
Bernese mountain dogs (n = 197) Control dogs (n = 57) P
Gender
Female 126/197 (64.0%) 29/57 (50.9%) 0.085
Male 71/197 (36.0%) 28/57 (49.1%)
age (years)
mean, range
3.9 (0.5–13) 4.5 (1–12) 0.079
weight (kilograms)
(mean, range)
39.64 (25–68) 38.96 (30–67) 0.491
Environment
Urban 59/197 (29.9%) 17/57 (29.8%) 0.986
Rural 138/197 (70.1%) 40/57 (70.2%)
Number of walks per week in grassland or forest < 1: 6/197 (3.0%) < 1: 4/57 (7.0%) 0.684
1–3: 67/197 (34.0%) 1–3: 17/57 (29.8%)
> 3: 124/197 (62.9%) > 3: 36/57 (63.2%)
tick exposure
Never 17/197 (8.6%) 4/57 (7.0%) 0.728
Rare 57/197 (28.9%) 16/57 (28.1%)
Occasionally 71/197 (36.0%) 27/57 (47.4%)
Frequent 52/197 (26.4%) 10/57 (17.5%)
Regular tick prevention (every 6 weeks) 126/197 (64.0%) 32/57 (56.1%) 0.298
Table 2 Results of haematology and serum biochemistry of Bernese mountain dogs and control dogs





Mean SD Mean SD
Haematocrit (l/l) 48.13 +/− 5.448 48.32 +/− 5.932 0.643
WBC (k/μl) 8.47 +/−2.429 7.99 +/−3.363 0.171
Urea (nmol/l) 9.61 +/− 5.522 6.85 +/− 1.831 < 0.001
Creatinine (μmol/l) 115.70 +/− 61.487 82.30 +/− 16.727 < 0.001
Total protein (g/l) 66.17 +/− 6.613 64.84 +/− 5.902 0.245
Albumin (g/l) 36.46 +/− 3.044 33.97 +/− 4.563 < 0.001
Phosphorus (mmol/l) 1.50 +/− 0.501 1.25 +/− 0.291 < 0.001
bold = significant difference
SD standard deviation, WBC white blood count
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control dogs. Interestingly, renal azotemia was the most
common abnormality and was more common than pro-
teinuria in this population of BMDs, and none of the
BMDs had proteinuria without azotemia. Persistent pro-
teinuria quantified by measuring UPC in a urine sample
with an inactive urine sediment is the hallmark of glom-
erular disease and is the only laboratory abnormality
present in early stages of this disease [16, 19]. However,
all dogs with azotemia without proteinuria had mild azo-
temia with creatinine values between 126 μmol/l to
174 μmol/l and, even though the USG was below 1.030,
none of these dogs was isosthenuric. Not being fasted
and higher muscle mass are possible reasons for in-
creased creatinine as well, however, this would also
apply for the control dogs. Determination of symmetric
dimethylarginin (SDMA) would have helped to exclude
this influence but was not available when the study was
performed [20]. Therefore, it is possible that some of the
dogs would not have been classified as dogs with renal
disease if repeated measurements of creatinine and USG
or measurement of glomerular filtration rate (GFR) were
performed to confirm the presence of renal disease. A
UPC of > 0.5 is abnormal for a dog but there is no clear
cut off for UPC that is diagnostic for any specific renal
disease because the overlap in ranges is too broad to be
clinically reliable [19]. However, there is a consensus
that with increasing magnitude of proteinuria assessed
by UPC, there is also increased likelihood for primary
glomerular disease [19, 21]. While renal proteinuria with
UPC values between 0.5 and 2.0 can be due to tubuloin-
terstitial disease, glomerular disease, or a combination of
both, UPC ≥ 2, which was observed in ten dogs in the
present study, is sufficiently high to suggest the presence
of pathological glomerular proteinuria and therefore pri-
mary glomerular disease [19]. These ten dogs in the
present study had UPC values between 2.1 and 6.4, they
Table 3 Urinalysis results of Bernese Mountain dogs and control dogs





USGa, (median, range) 1.030 (1.004–1.050) 1.029 (1.008–1.048) 0.684
Proteinb (median, range) + (neg - +++) Neg (neg - ++) 0.108
pHb (median, range) 6 (5–9) 6 (5–8) 0.277
Bilirubin b (median, range) Neg (neg – ++) Neg (neg – +) 0.204
Glucoseb (median, range) Neg (neg – 2) Neg (neg – 2) 0.566
Bloodb Neg (neg – ++++) Neg (neg – +++) 0.163
WBCs/ hpf (median, range) Neg (neg – 22) Neg (neg – 22) 0.906
UPC mean +/− SD (n = 189) (n = 56)
0.32 +/− 0.853 0.08 +/− 0.127 < 0.001
bold = significant difference
neg negative, SD standard deviation
a Urine specific gravity was determined by a hand refractometer
b Protein, bilirubin, pH, glucose, blood were analysed by dipstick analysis
c Urine protein and creatinine were measured with an automated analyser
Table 4 Prevalence of antibodies and signalement in Bernese Mountain dogs (BMDs) with and without laboratory evidence of
kidney disease
BMDs without evidence of kidney
disease (n = 162)
BMDs with evidence of kidney
disease (n = 35)
BMDs with UPC≥




3.7 (1–13) 5.2 (2–8) 5.1 (1–11) 0.652
Female 117/162 9/35 1/10 <
0.001
Male 45/162 26/35 9/10 <
0.001
Positive for Borrelia burgdorferi antibodies 69/162 (42.6%) 19/35 (54.3%) 6/10 (60.0%) 0.288
Positive for Anaplasma spp. antibodies 79/162 (48.7%) 12/35 (34.3%) 2/10 (20.0%) 0.079
Positive for antibodies against Anaplasma spp.
and Borrelia burgdorferi
40/162 (24.7%) 4/35 (11.4%) 1/10 (10.0%) 0.148
Positive for antigen of Dirofilaria immitis 0/162 (0%) 1/35 (2.9%) 1/10 (10.0%) 0.334
Positive for antibodies against Ehrlichia canis 0/162 (0%) 0/35 (0%) 0/10 (0%)
bold = significant difference
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were all azotemic, and had a USG < 1.020 [7, 8]. Inter-
estingly, that even though all these dogs had a USG <
1.020, owners did not recognize their dogs as being poly-
dipsic and polyuric. To the owners and upon physical
examination these dogs appeared healthy, but regarding
the relevant laboratory parameters, these ten dogs re-
semble dogs of previous reports on familial MPGN in
BMDs that had more pronounced proteinuria (UPC 4–
30) and azotemia as well [7, 8]. Seventeen of the 35 dogs
with renal azotemia had a UPC between 0.5 and 2,
which can be due to tubulointerstitial disease, glomeru-
lar disease, or a combination. It is possible that these
dogs were in an early stage of MPGN and had additional
tubulointerstitial nephritis with less pronounced labora-
tory abnormalities or a different disease entity.
In the present study, 77.1% (27/35) and 90.0% (9/10)
of dogs with laboratory evidence of kidney disease and
evidence of glomerulopathy, respectively, were male.
This is different from the 1:4 ratio of males to females
that has been reported for BMDs with familiar MPGN
[7, 8] but similar to the gender distribution of a study
performed in Switzerland with 160 BMDs [22]. In that
study, 11/160 dogs (6.7%) had evidence of kidney disease
defined as UPC > 0.3 in an inactive urine sediment [22].
In the Swiss study, three of these eleven BMDs with
UPC > 0.3 had mild renal azotemia. While only 28.1%
(45/160) of the total study population were male dogs,
82% (9/11) of dogs with evidence of kidney disease were
male [22]. In the present study as well, male BMDs (27/
35, 77.1%) were significantly more likely to have labora-
tory evidence of kidney disease than female BMDs (8/35,
22.9%) despite female BMDs being over-represented in
the overall study population (126/197; 63.6%). This gen-
der distribution could indicate that BMDs might be pre-
disposed for other forms of renal disease that affect male
individuals with greater frequency.
The average age of BMDs with evidence of kidney dis-
ease in the present study was 5.2 years. The mean age of
dogs with evidence of glomerular disease was 5.1 years
with no difference between dogs with UPC > 2 and those
with UPC between 0.5 and < 2 or renal azotemia only.
Compared to a study in the UK in which only around
10% of dogs with CKD were younger than 7 years [23],
dogs in the present study were affected at a young age.
This suggests that there is not only a breed predispos-
ition for glomerular but also for tubulointerstitial kidney
disease in BMDs.
In the present study, there was no correlation between
the presence of laboratory abnormalities indicating kid-
ney disease and the presence of antibodies against B.
burgdorferi and Anaplasma spp.. In a previous study in-
cluding 53 B. burgdorferi antibody-positive and -negative
BMDs and 30 antibody-positive and -negative control
dogs [24], dogs were followed for more than 2 years after
they had been tested positive for B. burgdorferi anti-
bodies. There were, however, no alterations in laboratory
parameters (blood and urine) that would indicate devel-
opment of renal disease [24].
The higher prevalence of antibodies to B. burgdorferi
sensu lato and Anaplasma spp. in BMDs compared with
control dogs indicates a breed predisposition to infection
with B. burgdorferi sensu lato and Anaplasma spp.
which is in agreement with the results of other studies
[14, 25]. In the present study, the effects of coat colour,
hair length, size and living conditions on antibody titers
were controlled for by using control dogs that were
heavier than 30 kg, had long dark hair and lived in envi-
ronments similar to those of the BMDs. Therefore, this
difference cannot be attributed to environmental factors.
A satisfying explanation for the high prevalence of anti-
bodies to B. burgdorferi sensu lato and Anaplasma spp.
in BMDs has not been established.
Only one BMD (1/267) of all dogs included in the
study was D. immitis antigen-positive. This BMD had a
UPC > 2, and an infestation with D. immitis could be re-
sponsible for the proteinuria in this BMD.
The most common biochemical findings that have
been reported in dogs with Anaplasma spp. and B. burg-
dorferi infections are hyperproteinaemia, hypoalbumi-
naemia and hypoproteinaemia [18, 26, 27]. In the
present study, there was no difference in serum total
protein serum albumin between antibody-positive and
antibody-negative dogs. The significantly higher albumin
in BMDs compared to control dogs did not exceed the
reference range and was not considered to be of clinical
relevance.
This study has several limitations. Firstly, dogs in-
cluded in this study were tested only once and thus
comparison or confirmation of initial and follow-up re-
sults was not possible. To diagnose persistent renal pro-
teinuria, ideally two or more urine samples collected
several weeks apart would have been desirable. This is
also true for USG and serum creatinine which are influ-
enced by extrarenal factors, such as hydration status and
diet, and repeated measurement would be preferable to
document persistence of abnormal results [28]. In
addition, determination of SDMA would have been par-
ticularly helpful to exclude the influence of the muscle
mass [29].
Secondly, in the present study, only routine renal func-
tional parameters creatinine, urea, USG and UPC were
used for assessment of renal function. More sensitive
markers for GFR (SDMA and cystatin C), tubular dam-
age (urinary neutrophil gelatinase-associated lipoprotein
(uNGAL), urinary retinol-binding protein (uRBP)), and
glomerular damage (urinary immunoglobulin G and
urirnary C-reactive protein) were not measured. Urinary
NGAL and uRBP have been shown to detect possible
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acute tubular injury not identified with conventional
renal parameters creatinine, urea and USG in dogs with
parvovirus enteritis [30], and babesiosis [31]. However,
UPC had the capacity to detect acute kidney injury as
well. Therefore, it is unlikely that the use of more sensi-
tive markers of kidney injury would have led to markedly
different results.
Conclusions
In conclusion, BMDs had more often laboratory evi-
dence of kidney disease than control dogs. Male dogs
were affected nearly ten times as often as female dogs
(OR 9.6). Furthermore, BMDs had a higher prevalence
of antibodies to B. burgdorferi sensu lato and Anaplasma
spp. than control dogs of various breeds. There was no
correlation between laboratory parameters indicating
renal disease and the presence of antibodies to B. burg-
dorferi sensu lato and Anaplasma spp..
Methods
Data acquisition
The clinical data and laboratory test results were derived
from data collected for another study with prospectively
enrolled dogs [15]. Apart from the published results,
additional data was collected and additional laboratory
tests were performed for the study that have not yet
been analyzed. Data analysis for the current study was
approved by the ethical committee of the veterinary fac-
ulty of the LMU Munich (210–04-04-2020).
Dogs
A total of 197 purebred BMDs (verified by registry cer-
tificates) and 57 control dogs originating from the same
areas in Southern Germany were included in the study.
For control dogs, the selection criteria for inclusion in
the study were a long, dark hair coat and a body weight
of more than 30 kg, which is comparable with that of
BMDs. All control dogs lived in the same households as
the BMDs or in the same neighborhoods. The control
group consisted of 29 female dogs (10 spayed) and 28
male dogs (13 neutered) ranging in age from 1 to 12
years (median: 4.5 years).
Bernese Mountain Dogs were located with the help of
breeder clubs and consisted of 126 females (27 spayed)
and 71 males (18 neutered) ranging in age from
6 months to 13 years (median: 3.9 years).
All dogs underwent a physical examination and blood
sampling, and all of the dogs were examined by the same
veterinarian (first author). Owners were asked to answer
a detailed questionnaire regarding clinical signs, environ-
ment, tick exposure, tick prevention, and vaccination
history of their dogs.
Laboratory variables
Haematocrit, white blood cell count (WBC), a partial
serum biochemical profile, and urinalysis were per-
formed for all dogs. For the serum biochemical profile,
blood samples collected from the jugular or cephalic
vein were placed in plastic serum tubes, and then were
allowed to clot for 30 min. Samples were centrifuged at
3000 rpm (RPM) for 10 min and the serum was har-
vested. Serum biochemical analysis was performed using
an automated analyser (Hitatchi 911; Roche Deutschland
Holding GmbH, Grenzach-Wyhlen, Germany) and in-
cluded the following parameters: the concentration of
urea, creatinine, total protein, albumin, and phosphorus.
The Cell Dyn 3500 (Fa. Abbott, Wiesbaden) was used
for determination of the haematocrit and the WBC.
Urine samples were collected by cystocentesis in all
254 dogs. A complete urinalysis including determin-
ation of the USG, a dipstick analysis, and microscopic
examination of the urine sediment was performed.
The USG was determined with a refractometer (ATC;
Müller GmbH, Erfurt, Germany). For examination of
the urine sediment, urine was centrifuged at 1500
RBM for 5 minutes. The urine sediment was assessed
for the presence of red blood cells, white blood cells,
and bacteria in 20 fields using a 40 x objective lens.
UPC was determined from the supernatant using an
automated analyser (Hitatchi 911; Roche Deutschland
Holding GmbH, Grenzach-Wyhlen, Germany). UPC
was not determined in nine dogs because they had
more than five leukocytes per field or bacteria in the
urine sediment.
Laboratory evidence of kidney disease was defined
as renal azotemia (creatinine > 125 μmol/l and USG <
1.030) and/or an increased UPC (UPC ≥ 0.5). Add-
itionally, BMDs with UPC ≥ 2.0 were categorized as a
separate group because a UPC ≥ 2 is sufficiently high
to suggest the presence of pathological glomerular
proteinuria and therefore glomerular disease [19].
Antibody testing
Whole blood samples were collected from a jugular or
cephalic vein in all dogs and tested for anti-B. burgdor-
feri sensu lato, anti-Anaplasma spp., anti-E. canis anti-
bodies and Dirofilaria immitis antigen using the
SNAP®4Dx® ELISA (IDEXX, Laboratories, Inc., West-
brook, ME, USA) according to the manufacturer’s in-
structions. Briefly, each test kit consisted of a coated
matrix with a result window containing five spots; colour
development in the spots indicated the presence of anti-
B. burgdorferi, anti-Anaplasma spp. and anti-Ehrlichia
canis antibodies and Dirofilaria immitis antigen. The
fifth spot served as a positive control. The wash and sub-
strate solutions were placed in two separate chambers,
and after activation of the test kit, the solutions flowed
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across the coated matrix. The test was performed imme-
diately after blood collection using whole blood.
Statistical analysis
Data were recorded and analysed using the commercial
computer program SPSS Statistics version 24.0 (IBM
Deutschland GmbH, Munich, Germany). Differences
were considered significant at p < 0.05. The Chi-square
test or Fisher’s exact test were used for investigation of
the categorical parameters of the urinalysis and for the
investigation of the differences of antibodies and antigen
between the different groups. The other laboratory find-
ings of BMDs and controls dogs were compared using
the nonparametric Mann Whitney U test. The Mann
Whitney U test was also used to analyse differences in
laboratory findings between antibody-positive and
antibody-negative dogs.
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